Loading clinical trials...
Loading clinical trials...
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting B-cell Lymphoma 2 (BCL-2)
Conditions
Locations
20
Italy
ASST Cremona
Cremona, CR, Italy
A.O. Pugliese Ciaccio
Catanzaro, CZ, Italy
Irst Irccs
Meldola, FC, Italy
AOU Careggi
Florence, FI, Italy
IRCCS Casa Sollievo sofferenza
San Giovanni Rotondo, Foggia, Italy
Ospedale F. Spaziani
Frosinone, FR, Italy
Start Date
August 23, 2019
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
April 21, 2020
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT04628026
NCT06994676
Lead Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions